Just yesterday, UNICEF released its 2025 Global HIV Estimates — and the numbers are a sobering call to action. While the world has made undeniable progress in reducing HIV infections among children, ...

The World Health Organization has recommended the use of injectable lenacapavir (LEN) twice a year as an additional ...

In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE ...

The World Health Organization (WHO) on Monday recommended countries to use the twice-a-year lenacapavir injection as an add ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...